Renal Impairment and Addiction Pharmacotherapy: Adjusting Naltrexone, Acamprosate, Gabapentin, and Topiramate

2026

View at publisher
Authors: Kevin A. Sevarino
DOI: 10.64239/pi-vl10206
Cited by: 0

Fields of Study & Subjects

Substance Abuse Treatment and Outcomes Opioid Use Disorder Treatment Pharmaceutical Practices and Patient Outcomes

Publication details

Publication date
6 March 2026
Language
EN